Evidence map›Paper›PMID 39829636›Full record

ArticleOpen forum infectious diseases2025

Dynamics of Persistent Submicroscopic and Microscopic

Sayeh Jafari-Guemouri, Robinson Dégbègni, Laura Courtois, Manfred Accrombessi, Achille Massougbodji, Xavier C Ding, Nicaise Tuikue Ndam, Atika Mama, Nadine Fievet, Véronique Sarrasin-Hubert and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Sayeh Jafari-GuemouriUMR261 MERIT, Université Paris Cité, IRD, Paris, France.ORCID https://orcid.org/0000-0002-8424-332X
Robinson DégbègniClinical Research Institute of Benin (IRCB), Abomey-Calavi, Benin.
Laura CourtoisGenetics Department, Institut Curie, PSL Research University, Paris, France.
Manfred AccrombessiClinical Research Institute of Benin (IRCB), Abomey-Calavi, Benin.
Achille MassougbodjiClinical Research Institute of Benin (IRCB), Abomey-Calavi, Benin.
Xavier C DingAbbott Rapid Diagnostics, Baar, Switzerland.ORCID https://orcid.org/0000-0001-8409-3678
Nicaise Tuikue NdamUMR261 MERIT, Université Paris Cité, IRD, Paris, France.
Atika MamaClinical Research Institute of Benin (IRCB), Abomey-Calavi, Benin.
Nadine FievetUMR261 MERIT, Université Paris Cité, IRD, Paris, France.
Véronique Sarrasin-HubertCentre National de Référence du Paludisme, Paris, France.
Gilles CotrellUMR261 MERIT, Université Paris Cité, IRD, Paris, France.
Valérie BriandUMR261 MERIT, Université Paris Cité, IRD, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Malaria infections in pregnancy are a major cause of maternal morbidity and neonatal mortality in sub-Saharan Africa. A high proportion of these infections are submicroscopic, which are usually asymptomatic and therefore untreated during pregnancy. Intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) aims to prevent and treat all potential infections whether submicroscopic or not. However, the resistance of parasites to SP is steadily increasing. The dynamic of microscopic and submicroscopic infections in a cohort of Beninese women throughout their pregnancy and its relation to IPTp-SP has been assessed. Methods: As a subsample of the RECIPAL project, 130 women with at least 2 infections detected by polymerase chain reaction during their pregnancy were included. Infections were categorized as new (isolated) or persistent based on Results: A total of 73.1% of women (95 women of 130) had exclusively persistent infections throughout their pregnancy, whereas only 7.7% (10 of 130) had exclusively new infections. During pregnancy, the median time spent with 1 persistent infection was 7.2 weeks. A considerable proportion of these persistent infections 64.3% (72 of 113) was only submicroscopic. Approximately 20% of these persistent infections occurred despite the use of IPTp-SP. Conclusions: Using new antimalarial combinations could contribute to limit the persistence of submicroscopic infections and their probable negative effects on the mother and the fetus.

Indexed as

intermittent preventive treatmentmsp-2 fragment analysis methodplasmodium falciparumpregnancysubmicroscopic

Identifiers

PMID39829636
PMCPMC11739809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.